Krystal Biotech (KRYS) Selling, General & Administrative (2016 - 2026)
Krystal Biotech (KRYS) posted Selling, General & Administrative of $39.85 million for Q2 2026, up 13.6% from $35.07 million a year earlier but down 2.8% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Selling, General & Administrative (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Krystal Biotech was $159.89 million, up 25.2% year-over-year; for FY2025, it was $146.74 million, up 29.1% from FY2024.
- Annual Selling, General & Administrative has increased for nine consecutive years, with a five-year compound annual growth rate of 57.7% (FY2020 to FY2025).
- In prior years, Krystal Biotech's Selling, General & Administrative was $113.63 million in FY2024 (+15.6%), $98.29 million in FY2023 (+26.4%), $77.74 million in FY2022 (+92.5%) and $40.39 million in FY2021 (+168.1%).
- Quarterly Selling, General & Administrative has run from a low of $9.57 million in Q3 2021 to a high of $41.45 million in Q4 2025 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last 35 quarters, with growth averaging 25.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Selling, General & Administrative ran from 2.6% in Q4 2023 to 171.0% in Q4 2021.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $41.01 million (Q1 2026), $41.45 million (Q4 2025) and $37.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Krystal Biotech | 9.54 Bn | 6.31 Bn | 112.79 Mn | 39.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.85 Mn |
| Mar 31, 2026 | 41.01 Mn |
| Dec 31, 2025 | 41.45 Mn |
| Sep 30, 2025 | 37.58 Mn |
| Jun 30, 2025 | 35.07 Mn |
| Mar 31, 2025 | 32.65 Mn |
| Dec 31, 2024 | 31.29 Mn |
| Sep 30, 2024 | 28.67 Mn |
| Jun 30, 2024 | 27.63 Mn |
| Mar 31, 2024 | 26.06 Mn |
| Dec 31, 2023 | 24.65 Mn |
| Sep 30, 2023 | 23.70 Mn |
| Jun 30, 2023 | 25.90 Mn |
| Mar 31, 2023 | 24.04 Mn |
| Dec 31, 2022 | 24.03 Mn |
| Sep 30, 2022 | 19.94 Mn |
| Jun 30, 2022 | 17.86 Mn |
| Mar 31, 2022 | 15.91 Mn |
| Dec 31, 2021 | 12.87 Mn |
| Sep 30, 2021 | 9.57 Mn |
API Access
Krystal Biotech Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();